Canagliflozin/rosuvastatin interactionRhabdomyolysis and hepatocellular injury: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1820卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82901-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：81 / 81

相关论文

共 50 条

[1] Rosuvastatin/ticagrelor interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2020, 1814 (1) : 317 - 317
[2] Rosuvastatin/ticagrelor interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2017, 1676 (1) : 260 - 260
[3] Pazopanib/rosuvastatin interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2018, 1688 (1) : 185 - 185
[4] Rosuvastatin/ticagrelor interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2023, 1947 (1) : 353 - 353
[5] Rosuvastatin/tacrolimus interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2011, 1363 (1) : 36 - 36
[6] Entecavir/rosuvastatin interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2022, 1905 (1) : 207 - 207
[7] Antiretrovirals/gemfibrozil/rosuvastatin interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2011, 1364 (1) : 8 - 8
[8] Abiraterone acetate/rosuvastatin interactionRhabdomyolysis and acute kidney injury following pharmacokinetic interaction between abiraterone acetate and rosuvastatin : case report
[J]. Reactions Weekly, 2021, 1845 (1) : 14 - 14
[9] Rosuvastatin/ticagrelor interactionRhabdomyolysis due to increased rosuvastatin concentration secondary to ticagrelor-induced acute kidney injury: case report
[J]. Reactions Weekly, 2018, 1699 (1) : 264 - 264
[10] Rosuvastatin/warfarin interactionRhabdomyolysis followed by medication error and overdose: case report
[J]. Reactions Weekly, 2020, 1815 (1) : 292 - 292

← 1 2 3 4 5 →